Cargill introduces EpiCor Pets postbiotic ingredient for North American market
Cargill has launched EpiCor® Pets, a postbiotic ingredient derived from a natural fermentation process, for the North American pet food and supplement market. The ingredient is designed to support immune defenses and gut health in dogs.
Agricultural giant Cargill has introduced EpiCor® Pets, a postbiotic ingredient aimed at the North American pet food and supplement industry. This ingredient is produced through a natural fermentation process, yielding metabolites and compounds intended to support immune function and gut health in dogs.
Postbiotics represent a category of health ingredients that differ from probiotics and prebiotics. Unlike probiotics, which are live microorganisms, and prebiotics, which serve as food for microbes, postbiotics are the beneficial compounds and byproducts that result from microbial fermentation. EpiCor® Pets delivers these components directly to the animal.
Cargill states that EpiCor® Pets is formulated with human-grade ingredients and is Non-GMO Project Verified. It is also free from common pet food allergens such as grains, corn, wheat, and soy. The ingredient is noted for its stability during typical pet food manufacturing processes, including extrusion, and possesses a palatable flavor for dogs.
The company highlights that the EpiCor® brand has established efficacy, supported by numerous published studies, including research involving both humans and dogs. This new offering for pets addresses a growing market demand for natural, scientifically-backed ingredients promoting animal well-being.